Evidence map›Paper›PMID 33804755›Full record

ArticleCells2021

A Molecular Networking Strategy: High-Throughput Screening and Chemical Analysis of Brazilian Cerrado Plant Extracts against Cancer Cells.

Patrícia C Cortelo, Daniel P Demarque, Renata G Dusi, Lorena C Albernaz, Raimundo Braz-Filho, Ekaterina I Goncharova, Heidi R Bokesch, Kirk R Gustafson, John A Beutler, Laila S Espindola

Abstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patrícia C CorteloLaboratório de Farmacognosia, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Brasília 70910-900, Brazil.ORCID 0000-0001-9946-5139
Daniel P DemarqueLaboratório de Farmacognosia, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Brasília 70910-900, Brazil.ORCID 0000-0002-3576-5148
Renata G DusiLaboratório de Farmacognosia, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Brasília 70910-900, Brazil.
Lorena C AlbernazLaboratório de Farmacognosia, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Brasília 70910-900, Brazil.
Raimundo Braz-FilhoFAPERJ/Departamento de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica, 23897-035 RJ, Brazil and Laboratório de Ciências Químicas, Universidade Estadual do Norte Fluminense, Campos dos Goytacazes, 28013-600 RJ, Brazil.ORCID 0000-0001-7217-3494
Ekaterina I GoncharovaMolecular Targets Program, National Cancer Institute, Frederick, MD 21702, USA.
Heidi R BokeschMolecular Targets Program, National Cancer Institute, Frederick, MD 21702, USA.
Kirk R GustafsonMolecular Targets Program, National Cancer Institute, Frederick, MD 21702, USA.ORCID 0000-0001-6821-4943
John A BeutlerMolecular Targets Program, National Cancer Institute, Frederick, MD 21702, USA.ORCID 0000-0002-4646-1924
Laila S EspindolaLaboratório de Farmacognosia, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Brasília 70910-900, Brazil.ORCID 0000-0002-1886-868X

Funding

Building Libraries with Chemical Diversity for ScreeningZIABC011469 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BEUTLER, JOHN · 2012 to 2025
$7.8M
Conselho Nacional de Desenvolvimento Científico e Tecnológico 249213/2013-3Ministério da Saúde TED 42/2017Ministério da Saúde TED 74/2016
6 · The paper itself

Abstract

Plants have historically been a rich source of successful anticancer drugs and chemotherapeutic agents, with research indicating that this trend will continue. In this contribution, we performed high-throughput cytotoxicity screening of 702 extracts from 95 plant species, representing 40 families of the Brazilian Cerrado biome. Activity was investigated against the following cancer cell lines: colon (Colo205 and Km12), renal (A498 and U031), liver (HEP3B and SKHEP), and osteosarcoma (MG63 and MG63.3). Dose-response tests were conducted with 44 of the most active extracts, with 22 demonstrating IC

Indexed as

EcosystemHigh-Throughput Screening AssaysBrazilCell Line, TumorGeographyHumansInhibitory Concentration 50Plant ExtractsSolventsPlant ExtractsSolventsBrazilian Cerrado biomecancer cell lineshigh-throughput screeningmass spectrometrymolecular networkingNCI-60 cancer cell linesplant extracts

Identifiers

PMID33804755
PMCPMC8004027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.